Combination therapy with glatiramer acetate and riluzole

Details for Australian Patent Application No. 2005218625 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Hayardeny, Liat; Blaugrund, Eran; Klinger, Ety

Agent FB Rice

Pub. Number AU-A-2005218625

PCT Pub. Number WO2005/084377

Priority 60/549,975 03.03.04 US; 60/549,976 03.03.04 US; 60/549,974 03.03.04 US

Filing date 3 March 2005

Wipo publication date 15 September 2005

International Classifications

A61K 31/428 (2006.01) - condensed with carbocyclic rings

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/084377 Priority application(s): WO2005/084377

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005218627-Method and apparatus for receive diversity control in wireless communications

2005218624-Rotating systems associated with drill pipe